Delivery Order SPE2DB22D9765-SPE2DB24FH0GE

Award Date 6/13/24
Potential Completion Date 7/8/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $7,737.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that supports the recurring pharmaceutical supply needs of military health facilities worldwide. Under this contract, DMS Pharmaceutical Group will provide the...
The Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract, valued at $9,284.40, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that allows the agency to issue orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is to provide the specialized drug Xolair 150 mg/mL syringe. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the DLA to place delivery orders for a wide range of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $3,094.80, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $37,137.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGE and has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a large $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $15,474.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a completion date of January 7, 2025, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $15,474.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under the DLA's SPE2DB pharmaceutical Prime Vendor program, is for the provision of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a completion date of November 20, 2024. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of 4566606230 - XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through December 18, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the biologic drug Xolair 150 mg/ml syringes. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue orders...
  • SPE2DB22D9765
    Indefinite Delivery Contract
  • SPE2DB22D9765-SPE2DB24FH0GE
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The contract is for the delivery of the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML, with a completion date of July 8, 2024. DMS Pharmaceutical Group is a prime contractor for the DLA and Department of Veterans Affairs (VA), providing a wide range of pharmaceutical products and medical supplies to support the recurring medical supply needs of military health facilities and VA medical centers nationwide.

Generated 9/12/24, 1:06 PM